The Kenya Pharma project works, in collaboration with the National AIDS and Sexually Transmitted Disease Control Program (NASCOP), to develop and manage a sustainable, uninterrupted supply of pharmaceuticals and other supplies for people living with HIV/AIDS. The project services approximately 350 sites with Antiretroviral (ARV) medicine and has expanded into drugs to treat opportunistic infections (OI).
The project is responsible for managing the entire supply chain from forecasting and quantification to delivery. The project provides commodities for 65% of Kenyans currently on Antiretroviral Treatment medicines.
The project is responsible for managing the entire supply chain from forecasting and quantification to delivery. The project provides commodities for up to 275,000 patients on ARVs and 750,000 patients on OI drugs during its second year.
More specifically Kenya Pharma will:
• Quantify ARVs and OI drugs needed to meet USG targets
• Procure the required pharmaceuticals and other commodities
• Properly store and warehouse PEPFAR commodities
• Distribute pharmaceuticals in a timely and efficient manner to ensure continuity in patient treatment
• Perform regular quality assurance reviews of the commodities procured and their distribution through recognized quality control laboratories
• Maintain records on supply for monitoring and evaluation of the project.
Kenya Pharma has successfully:
• Established Ministry of Health-approved warehousing space
• Transitioned products and responsibilities from the previous implementer
• Validated and mapped the list of Antiretroviral Treatment (ART) clinics serviced by the project in conjunction with NASCOP
• Put into place a team of field agents to provide support and service to PEPFAR/Kenya Pharma clinics
• Designed a real-time, web-based electronic supply chain management system (eSCM) to assist in information transfer and sharing on supply status and ordering
• Established regular ordering and re-supply systems for project commodities
• Delivered 868,134 kg of ARV and OI pharmaceuticals to more than 350 clinics from August 2009 to March 2011.
• Worked with Indian manufacturers to improve performance and get the best prices for the commodities procured under this contract.
• Worked with NASCOP to review site allocations and reporting tools for harmonization across the supply chains.